Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Janssen-Cilag Pty Ltd
Scientific Title
A Phase 3 Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Subjects With Advanced Urothelial Cancer and Selected FGFR Gene Aberrations